Netupitant-Palonosetron FDC Market 2017-2027 Shares, Trend and Growth Report
Netupitant-Palonosetron is the first approved fixed dose combination drug for the prevention of chemotherapy induced nausea and vomiting. Cancer is a leading cause of death worldwide, accounting nearly 1.4 million new cases in 2012. The…